Can the Growth/Differentiation Factor-15 Be a Surrogate Target in Chronic Heart Failure Biomarker-Guided Therapy?

Can the Growth/Differentiation Factor-15 Be a Surrogate Target in Chronic Heart Failure Biomarker-Guided Therapy?

Heart failure (HF) biomarker-guided therapy is a promising method, which directs to the improvement of clinical status, attenuation of admission/readmission to the hospital and reduction in mortality rate. Many biological markers, like inflammatory cytokines, are under consideration as a surrogate t...

Full description

Bibliographic Details
Main Author: Alexander E. Berezin
Format: Article
Language:English
Published: Third Party Medicine International Publishing Group Co. Limited 2017-03-01
Series:Journal of International Translational Medicine
Subjects:
Heart failure
Growth/differentiation factor-15
Progenitor endothelial cell
Biomarkers
Online Access:http://www.jitm.hk/EN/abstract/abstract238.shtml

Similar Items

Similar Items